Refine by:
-
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter to House and Senate Committee leadership encouraging Congress to support robust FY 25 funding of at least $740M via the BRAIN Initiative for research on the causes, cures, and prevention of neurological and psychiatric disorders. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter to House and Senate Appropriations Committees requesting $35 million for the CDC, $25 million for the NIH, and $1 million for the NIJ to conduct public health research into firearm morbidity and mortality prevention. -
Regulatory Comment to the Bureau of Justice Statistics on Criminal Justice and Research and Treatment Innovation
Comment to the Bureau of Justice Statistics in support of efforts to collect information through the tool, “Capital Punishment Report of Inmates Under Sentence of Death,” and recommending the tool collect information on mental health treatment and diagnosis to document the disproportionate use of capital punishment toward people with serious mental illness. -
Letter to HHS on Research and Treatment Innovation and Medicare
Letter to HHS Secretary Becerra seeking greater data collection and focus on incentivizing integrated behavioral healthcare in the CMS Innovation Center’s new primary care model, ACO Flex. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation, Mental Health Funding and Criminal Justice
Letter to the House and Senate Appropriations Committees requesting the highest possible funding level in the FY 25 Commerce, Justice, Science Appropriations bill for the National Institute of Justice (NIJ) and Bureau of Justice Statistics (BJS) within the Department of Justice. -
Letter to Congressional Committee Leadership on Mental Health Funding and Research and Innovation
Letter encouraging Congress to support robust FY2025 funding of at least $740 million for the BRAIN Initiative. -
Letter to Congressional Committee Leadership on Mental Health Funding and Research and Innovation
Letter to Appropriations Committee leadership requesting $5 million for the FDA’s Neurology Drug Program to advance discoveries in all areas of brain health. -
Regulatory Comment to NCQA on Maternal Mental Health and Research and Treatment Innovation
Comment in response to the National Committee for Quality Assurance (NCQA)’s 2024 request for public comment on HEDIS Perinatal Depression Screening Measures, urging NCQA to add anxiety screening to the measures, require mandatory reporting of the measures, and exclude screening by insurer/health plan staff. -
Regulatory Comment to NCQA on Crisis Services and Research and Treatment Innovation
Regulatory comment supporting the NCQA’s Proposed Changes to Existing HEDIS Measures: Follow-Up After Emergency Department Visit for Mental Illness (FUM) and Follow-Up After Hospitalization for Mental Illness (FUH), and providing additional recommendations to strengthen the measures, including guidance on follow-up care. -
Letter To Congressional Committee Leadership On Research And Innovation And Mental Health Funding
Letter to Appropriations Committee leadership, requesting at least $680 million in FY24 for NIH’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.